Smith Salley & Associates lessened its stake in Monsanto (NYSE:MON) by 16.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,255 shares of the basic materials company’s stock after selling 447 shares during the quarter. Smith Salley & Associates’ holdings in Monsanto were worth $263,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MON. Farallon Capital Management LLC increased its holdings in Monsanto by 1,505.6% in the fourth quarter. Farallon Capital Management LLC now owns 1,445,000 shares of the basic materials company’s stock valued at $168,747,000 after purchasing an additional 1,355,000 shares during the last quarter. Canyon Capital Advisors LLC bought a new stake in shares of Monsanto in the fourth quarter worth about $147,437,000. York Capital Management Global Advisors LLC increased its holdings in shares of Monsanto by 14.8% in the fourth quarter. York Capital Management Global Advisors LLC now owns 6,059,514 shares of the basic materials company’s stock worth $707,630,000 after acquiring an additional 781,259 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Monsanto by 30.6% in the fourth quarter. Renaissance Technologies LLC now owns 2,881,300 shares of the basic materials company’s stock worth $336,478,000 after acquiring an additional 675,700 shares in the last quarter. Finally, Lansdowne Partners UK LLP bought a new stake in shares of Monsanto in the fourth quarter worth about $76,287,000. Institutional investors and hedge funds own 74.85% of the company’s stock.
Monsanto opened at $125.73 on Wednesday, MarketBeat.com reports. The company has a quick ratio of 0.85, a current ratio of 1.41 and a debt-to-equity ratio of 0.85. The stock has a market cap of $55.50 billion, a PE ratio of 22.86, a PEG ratio of 2.60 and a beta of 0.95. Monsanto has a fifty-two week low of $114.19 and a fifty-two week high of $126.80.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Thursday, April 5th. The basic materials company reported $3.22 earnings per share for the quarter, missing the consensus estimate of $3.31 by ($0.09). The firm had revenue of $5.02 billion for the quarter, compared to analyst estimates of $5.34 billion. Monsanto had a return on equity of 37.31% and a net margin of 17.07%. The firm’s quarterly revenue was down 1.1% on a year-over-year basis. During the same period in the prior year, the company earned $3.19 earnings per share. equities research analysts anticipate that Monsanto will post 5.7 EPS for the current fiscal year.
Several brokerages have issued reports on MON. ValuEngine downgraded Monsanto from a “buy” rating to a “hold” rating in a report on Wednesday, May 2nd. Sanford C. Bernstein restated a “neutral” rating and issued a $119.00 price target on shares of Monsanto in a report on Monday, April 9th. Zacks Investment Research downgraded Monsanto from a “hold” rating to a “sell” rating in a report on Monday, April 9th. Argus downgraded Monsanto from a “buy” rating to a “sell” rating in a report on Monday, April 16th. Finally, BMO Capital Markets downgraded Monsanto from an “outperform” rating to a “market perform” rating in a report on Tuesday, April 10th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $126.61.
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.